REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka Dla Zdrowia R. Bloch sp. j. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | Retail Trade | Real Estate | Ambulatory Health Care Services | Nursing and Residential Care Facilities | Social Assistance | Accommodation
Full name: Apteka Dla Zdrowia R. Bloch sp. j. Profile Updated: April 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Apteka Dla Zdrowia R. Bloch sp. j. is an enterprise located in Poland, with the main office in Lodz. The enterprise operates in the Department Stores industry. It was established on October 26, 2011. There was a net sales revenue increase of 5.8% reported in Apteka Dla Zdrowia R. Bloch sp. j.’s latest financial highlights for 2023. Over the same period, its total assets decreased by 6.17%. The net profit margin of Apteka Dla Zdrowia R. Bloch sp. j. increased by 2.7% in 2023.

Headquarters
Ul. Andrzeja Sacharowa 63
Lodz; Lodzkie; Postal Code: 92-518

Contact Details: Purchase the Apteka Dla Zdrowia R. Bloch sp. j. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteka Dla Zdrowia R. Bloch sp. j. report to view the information.
Incorporation Date:
October 26, 2011
Key Executives
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Apteka Dla Zdrowia R. Bloch sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
5.8%
Total operating revenue
5.4%
Operating profit (EBIT)
81.7%
Net Profit (Loss) for the Period
76.97%
Total assets
-6.17%
Total equity
23.85%
Operating Profit Margin (ROS)
2.9%
Net Profit Margin
2.7%
Return on Equity (ROE)
13.29%
Quick Ratio
0.03%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?